Association of morphine vs. fentanyl prescription dispensation with adverse clinical outcomes. Reyes C, Pou MA, Diaz-Torne C, Carbonell-Abella C, Brotons C, Martinez-Laguna D. Front Pharmacol. 2025 Jun 25;16:1579634. doi: 10.3389/fphar.2025.1579634. eCollection 2025.
[Effectiveness of the clinical assistant in the control of hypertensive and diabetic patients in primary care]. Galán M, Sellarès J, Monteserín R, Vicuña J, Moral I, Brotons C. Aten Primaria. 2024 Jun;56(6):102853. doi: 10.1016/j.aprim.2023.102853. Epub 2024 Jan 19.
How do Patients and Managers Value Gold Standard Elements in Primary Health Care. Gálvez G, Jimenez ML, Manzanera R, Ávalos A, De Castro M, Moral I, Iruela A. J Patient Exp. 2024 Oct 3;11:23743735241282702. doi: 10.1177/23743735241282702. eCollection 2024.
Patient’s experience as a tool in analyzing primary care in Catalonia. Iruela A, Moral I, Gálvez G, Jimenez LM, Manzanera R. J Healthc Qual Res. 2025 Mar-Apr;40(2):72-78. doi: 10.1016/j.jhqr.2024.10.002. Epub 2024 Nov 14.
Enhanced Safety Surveillance of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season. de la Cueva IS, Gerber JE, Hastie A, Brotons C, Panzer F, Pirçon JY, Talsma P, Eckermann T, Nikic V, Gomez XM, Alsdurf H. Drug Saf. 2024 Nov;47(11):1137-1148. doi: 10.1007/s40264-024-01456-y. Epub 2024 Jun 29.
Practices of low value or unnecessary practices in vascular prevention. Brotons C, Moral I, García Abajo JM, Caro Mendivelso J, Cortés Rico O, Díaz Á, Elosua R, Escribano Pardo D, Freijo Guerrero MM, González Fondado M, Gorostidi M, Goya Canino MM, Grau M, Guijarro Herraiz C, Lahoz C, Lopez-Cancio Martínez E, Rivas NM, Ortega E, Pallarés-Carratalá V, Rodilla E, Royo-Bordonada MÁ, Salmerón Febres LM, Santamaria Olmo R, Torres-Fonseca MM, Velescu A, Zamora A, Armario P. Hipertens Riesgo Vasc. 2025 Feb 15:S1889-1837(25)00025-X. doi: 10.1016/j.hipert.2025.01.002. Online ahead of print.
Perspectives of clinicians and screening candidates on shared decision-making in prostate cancer screening with the prostate-specific antigen (PSA) test: a qualitative study (PROSHADE study). Sanchis MJ, Guilabert M, Parker LA, Caballero-Romeu JP, Chilet-Rosell E, Gómez-Pérez L, Alonso-Coello P, Cebrián A, López-Garrigós M, Moral I, Ronda-Pérez E, Canelo-Aybar C, Hernández-Aguado I, Párraga I, Del Campo-Giménez M, Lumbreras B. BMJ Evid Based Med. 2025 May 20;30(3):163-172. doi: 10.1136/bmjebm-2024-113113.
